H. Lundbeck (US non-core product portfolio)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Portfolio of central nervous system products. The portfolio comprises rights to the non-core pharmaceutical products and drugs which addresses psychiatric and neurological disorders.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- United States
H. Lundbeck (US non-core product portfolio) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore H. Lundbeck (US non-core product portfolio)‘s full profile, request access.
Request full access to PitchBookH. Lundbeck (US non-core product portfolio) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore H. Lundbeck (US non-core product portfolio)‘s full profile, request access.
Request full access to PitchBook